Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.

Koutsonanos DG, Esser ES, McMaster SR, Kalluri P, Lee JW, Prausnitz MR, Skountzou I, Denning TL, Kohlmeier JE, Compans RW.

Vaccine. 2015 Sep 8;33(37):4675-82. doi: 10.1016/j.vaccine.2015.01.086. Epub 2015 Mar 3.

2.

Memory T cells generated by prior exposure to influenza cross react with the novel H7N9 influenza virus and confer protective heterosubtypic immunity.

McMaster SR, Gabbard JD, Koutsonanos DG, Compans RW, Tripp RA, Tompkins SM, Kohlmeier JE.

PLoS One. 2015 Feb 11;10(2):e0115725. doi: 10.1371/journal.pone.0115725. eCollection 2015.

3.

Influenza virus-specific neutralizing IgM antibodies persist for a lifetime.

Skountzou I, Satyabhama L, Stavropoulou A, Ashraf Z, Esser ES, Vassilieva E, Koutsonanos D, Compans R, Jacob J.

Clin Vaccine Immunol. 2014 Nov;21(11):1481-9. doi: 10.1128/CVI.00374-14. Epub 2014 Aug 27.

4.

Targeting the skin for microneedle delivery of influenza vaccine.

Koutsonanos DG, Compans RW, Skountzou I.

Adv Exp Med Biol. 2013;785:121-32. doi: 10.1007/978-1-4614-6217-0_13. Review.

5.

ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.

Yoon HS, Scharer CD, Majumder P, Davis CW, Butler R, Zinzow-Kramer W, Skountzou I, Koutsonanos DG, Ahmed R, Boss JM.

J Immunol. 2012 Sep 1;189(5):2393-403. doi: 10.4049/jimmunol.1103371. Epub 2012 Jul 30.

6.

Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine.

Weldon WC, Zarnitsyn VG, Esser ES, Taherbhai MT, Koutsonanos DG, Vassilieva EV, Skountzou I, Prausnitz MR, Compans RW.

PLoS One. 2012;7(7):e41501. doi: 10.1371/journal.pone.0041501. Epub 2012 Jul 25.

7.

Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection.

Koutsonanos DG, Vassilieva EV, Stavropoulou A, Zarnitsyn VG, Esser ES, Taherbhai MT, Prausnitz MR, Compans RW, Skountzou I.

Sci Rep. 2012;2:357. doi: 10.1038/srep00357. Epub 2012 Apr 12.

8.

Local response to microneedle-based influenza immunization in the skin.

del Pilar Martin M, Weldon WC, Zarnitsyn VG, Koutsonanos DG, Akbari H, Skountzou I, Jacob J, Prausnitz MR, Compans RW.

MBio. 2012 Mar 6;3(2):e00012-12. doi: 10.1128/mBio.00012-12. Print 2012.

9.

Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.

Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Jacob J, Prausnitz MR, Compans RW, Skountzou I.

J Infect Dis. 2011 Aug 15;204(4):582-91. doi: 10.1093/infdis/jir094. Epub 2011 Jun 17.

10.

Programming the magnitude and persistence of antibody responses with innate immunity.

Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI, Ravindran R, Stewart S, Alam M, Kwissa M, Villinger F, Murthy N, Steel J, Jacob J, Hogan RJ, GarcĂ­a-Sastre A, Compans R, Pulendran B.

Nature. 2011 Feb 24;470(7335):543-7. doi: 10.1038/nature09737.

11.

Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.

Weldon WC, Martin MP, Zarnitsyn V, Wang B, Koutsonanos D, Skountzou I, Prausnitz MR, Compans RW.

Clin Vaccine Immunol. 2011 Apr;18(4):647-54. doi: 10.1128/CVI.00435-10. Epub 2011 Feb 2.

12.

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O'Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC.

J Exp Med. 2011 Jan 17;208(1):181-93. doi: 10.1084/jem.20101352. Epub 2011 Jan 10. Erratum in: J Exp Med. 2011 Feb 14;208(2):411.

13.

Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.

Weldon WC, Wang BZ, Martin MP, Koutsonanos DG, Skountzou I, Compans RW.

PLoS One. 2010 Sep 1;5(9). pii: e12466. doi: 10.1371/journal.pone.0012466.

14.

Dissolving polymer microneedle patches for influenza vaccination.

Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR.

Nat Med. 2010 Aug;16(8):915-20. doi: 10.1038/nm.2182. Epub 2010 Jul 18.

15.

Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.

Skountzou I, Koutsonanos DG, Kim JH, Powers R, Satyabhama L, Masseoud F, Weldon WC, Martin Mdel P, Mittler RS, Compans R, Jacob J.

J Immunol. 2010 Aug 1;185(3):1642-9. doi: 10.4049/jimmunol.1000091. Epub 2010 Jun 28.

16.

Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge.

Martin Mdel P, Seth S, Koutsonanos DG, Jacob J, Compans RW, Skountzou I.

PLoS One. 2010 May 28;5(5):e10897. doi: 10.1371/journal.pone.0010897.

17.

Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine.

Skountzou I, Martin Mdel P, Wang B, Ye L, Koutsonanos D, Weldon W, Jacob J, Compans RW.

Vaccine. 2010 May 28;28(24):4103-12. doi: 10.1016/j.vaccine.2009.07.058. Epub 2009 Aug 3.

18.

Transdermal influenza immunization with vaccine-coated microneedle arrays.

Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, Skountzou I.

PLoS One. 2009;4(3):e4773. doi: 10.1371/journal.pone.0004773. Epub 2009 Mar 10.

Supplemental Content

Loading ...
Support Center